The European Commission has accused Kingspan, a major insulation and building materials company, of giving misleading information during the review of its 854 million euro acquisition of Recticel’s insulation division.
The Commission issued a Statement of Objections, indicating serious concerns that Kingspan’s actions might have affected its ability to evaluate the deal’s impact on competition.
Kingspan allegedly failed to disclose essential information about product certification, possibly distorting the market competition assessment.
If found guilty, Kingspan could face heavy fines, with penalties based on its annual global revenue. The company has stated it is reviewing the objections seriously and intends to cooperate with the investigation.
The case emphasizes the need for transparency in corporate deals and the EU’s dedication to enforcing competition laws. The outcome may set a precedent for handling similar cases in the future and reaffirms the EU’s commitment to a fair market.
There is no legal deadline for the Commission to complete such inquiries. Their duration depends on a number of factors, including the complexity of the case, the extent to which the companies concerned co-operate with the Commission and the exercise of the rights of defense.
Source: Mirage News
Featured News
FTC to Approve Exxon’s $64 Billion Deal with Pioneer Resources, Excludes
May 1, 2024 by
CPI
UK Competition Watchdog Raises Alarm Over Nvidia’s ARM Takeover
May 1, 2024 by
CPI
Sen. Klobuchar Urges Regulators to Probe Collusion in Health Care Pricing
May 1, 2024 by
CPI
Multiple States Join Tennessee’s Antitrust Lawsuit Against NCAA Over NIL Rules
May 1, 2024 by
CPI
NY AG Joins Suit Challenging NCAA’s Restrictions on Student Athlete NIL Rights
May 1, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI